These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 2652826)
1. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation. Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826 [No Abstract] [Full Text] [Related]
2. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation. Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502 [No Abstract] [Full Text] [Related]
3. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation? Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503 [No Abstract] [Full Text] [Related]
4. Consequences of conversion from cyclosporine to conventional therapy in renal transplantation. Abbud-Filho M; Barberato JB; Ramalho HJ; Saldanha LB; Casassanta DM; Denadai ER; Zerati S; Bezas AG Transplant Proc; 1989 Feb; 21(1 Pt 2):1638-40. PubMed ID: 2652535 [No Abstract] [Full Text] [Related]
5. Successful cadaveric renal transplantation in infants and young children. Ettenger RB; Rosenthal JT; Marik J; Salusky IB; Kamil E; Malekzadeh MH; Fine RN Transplant Proc; 1989 Feb; 21(1 Pt 2):1707-8. PubMed ID: 2652559 [No Abstract] [Full Text] [Related]
6. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive? Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657 [No Abstract] [Full Text] [Related]
7. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone. MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557 [No Abstract] [Full Text] [Related]
8. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine. Chapman JR; Morris PJ Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664 [No Abstract] [Full Text] [Related]
10. Conversion from standard cyclosporine to low-dose cyclosporine in liver transplant recipients: effect on nephrotoxicity and hypertension beyond one year. Eid A; Perkins JD; Rakela J; Krom RA Transplant Proc; 1989 Feb; 21(1 Pt 2):2238-9. PubMed ID: 2652725 [No Abstract] [Full Text] [Related]
11. Triple low-dose immunosuppression with cessation of steroids in pediatric renal transplantation. Walker RG; d'Apice AJ; Powell HR; Francis DM; Kincaid-Smith P Transplant Proc; 1988 Feb; 20(1):7-10. PubMed ID: 3278465 [No Abstract] [Full Text] [Related]
12. Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone. O'Connell P; d'Apice A; Walker R; Francis D; Kincaid-Smith P Transplant Proc; 1988 Feb; 20(1):11-3. PubMed ID: 3278450 [No Abstract] [Full Text] [Related]
13. Current results with triple therapy for heart transplantation. Bolman RM; Olivari MT; Saffitz J; Sibley R; Spadaro J; Cance C; Elick B Transplant Proc; 1987 Feb; 19(1 Pt 3):2490-1. PubMed ID: 3274544 [No Abstract] [Full Text] [Related]
14. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665 [No Abstract] [Full Text] [Related]
15. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function. Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536 [No Abstract] [Full Text] [Related]
16. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen? Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495 [No Abstract] [Full Text] [Related]
17. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine. Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493 [No Abstract] [Full Text] [Related]